Description
Triple Blend (CJC-1295 with DAC 2mg + Ipamorelin 2mg + GHRP-2 2mg) Research Overview
Disclaimer: The compounds described on this page are intended for laboratory research use only and are not approved for human consumption.
Overview of Triple Blend
Three peptides co-blended at 2mg + 2mg + 2mg (6mg total per vial, catalog code TRI6). This exact ratio has not been independently studied. Research Use Only; not FDA-approved; not for human or veterinary use. Requires IRB approval for human-subject research and IACUC approval for animal studies.
CJC-1295 with DAC
A synthetic GHRH (1-29) analogue conjugated to a Drug Affinity Complex (DAC) for extended half-life. Not a SARM.
CJC-1295 with DAC Chemical Properties
| Property | Details |
| CAS Number | 863288-34-0 |
| Compound Type | GHRH (1-29) analogue + DAC conjugate |
| Classification NOT a SARM | No androgen receptor activity |
| Classification NOT a ghrelin-receptor agonist | Acts via GHRH receptor, unlike Ipamorelin/GHRP-2 |
| Molecular Weight | ~3,647.8 g/mol |
| Chemical Formula | C165H271N47O46 |
| Synonyms | DAC:GRF, Mod GRF (1-29) with DAC |
| PubChem Reference | Verify per Certificate of Analysis |
| Physical Form | Lyophilized powder |
| Purity | Verify per Certificate of Analysis |
| Storage | Ultra-low freezer (-20°C or lower); protect from light/moisture |
| Shelf Life | Verify per Certificate of Analysis |
| Regulatory Status | Research Use Only (RUO); not FDA-approved |
Ipamorelin
A synthetic pentapeptide, selective agonist of the ghrelin receptor (GHS-R1a). Not a SARM.
Ipamorelin Chemical Properties
| Property | Details |
| CAS Number | 170851-70-4 |
| Compound Type | Pentapeptide ghrelin-receptor (GHS-R1a) agonist |
| Classification NOT a SARM | No androgen receptor activity |
| Classification NOT a GHRH analogue | Acts via ghrelin receptor, unlike CJC-1295 with DAC |
| Molecular Weight | ~711.85 g/mol |
| Chemical Formula | C38H49N9O5 |
| Synonyms | NNC-26-0161 |
| PubChem Reference | CID 9831659 |
| Physical Form | Lyophilized powder |
| Purity | Verify per Certificate of Analysis |
| Storage | Ultra-low freezer (-20°C or lower); protect from light/moisture |
| Shelf Life | Verify per Certificate of Analysis |
| Regulatory Status | Research Use Only (RUO); not FDA-approved |
GHRP-2
A synthetic hexapeptide, also a ghrelin-receptor (GHS-R1a) agonist. Not a SARM. Unlike Ipamorelin, it is reported to produce modest secondary effects on cortisol, prolactin, and appetite.
GHRP-2 Chemical Properties
| Property | Details |
| CAS Number | 158861-67-7 |
| Compound Type | Hexapeptide ghrelin-receptor (GHS-R1a) agonist |
| Classification NOT a SARM | No androgen receptor activity |
| Classification NOT identical to Ipamorelin | Same receptor, different sequence and broader hormone effects |
| Molecular Weight | ~817.97 g/mol |
| Chemical Formula | C45H55N9O6 |
| Synonyms | Pralmorelin, KP-102 |
| PubChem Reference | CID 6918245 |
| Physical Form | Lyophilized powder |
| Purity | Verify per Certificate of Analysis |
| Storage | Ultra-low freezer (-20°C or lower); protect from light/moisture |
| Shelf Life | Verify per Certificate of Analysis |
| Regulatory Status | Research Use Only (RUO); not FDA-approved |
How the Triple Blend Works in Research Models
CJC-1295 with DAC acts on the GHRH receptor; Ipamorelin and GHRP-2 both act on the ghrelin receptor (GHS-R1a), a separate pathway. Combining a GHRH-receptor agonist with a ghrelin-receptor agonist has shown synergistic GH release in published two-peptide studies. This specific three-peptide ratio has not been studied.
Risk & Handling
- Handle with gloves, eye protection, and a fume hood or biosafety cabinet.
- Keep frozen and away from light/moisture until needed.
- Only trained lab personnel should reconstitute or dose this product.
Why Consider Triple Blend for Research?
- Verified purity Tested per Certificate of Analysis (CoA)
- Identity verified LC-MS/HPLC analysis per lot
- Complete documentation Full CoA available on request
- Expert assistance Technical questions and compliance guidance
- Contact: help@ironmountainlabz.com
Frequently Asked Questions
Q1: What’s in this vial, one peptide or several?
Three peptides: CJC-1295 with DAC, Ipamorelin, and GHRP-2, 2mg each (6mg total). Don’t assume it acts like any single peptide alone.
Q2: Why isn’t there a study on this exact combination?
Each peptide is studied individually, and CJC-1295/Ipamorelin as a pair but not all three together in this ratio. Verify purity/stability from this product’s own CoA.
Q3: Why do two of these peptides (Ipamorelin, GHRP-2) seem similar?
Both hit the same receptor, but aren’t interchangeable. GHRP-2 has broader secondary hormone effects. CJC-1295 with DAC works through a different pathway entirely.
Q4: Who can buy and use this?
Qualified researchers at licensed institutions only. IRB approval required for human-subject work; IACUC approval for animal studies. Not for personal use.
Q5: How should this be stored and handled?
Ultra-low freezer (-20°C or colder), away from light/moisture. Use PPE (gloves, respirator, eye protection) and a fume hood/biosafety cabinet. Request the SDS from help@ironmountainlabz.com before first use.
References
- Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295 in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805. PMID: 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/
- Alba M, et al. Once-daily CJC-1295 normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006;291(6):E1290-1294. PMID: 16822960. https://pubmed.ncbi.nlm.nih.gov/16822960/
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. PMID: 9849822. https://pubmed.ncbi.nlm.nih.gov/9849822/
- Bowers CY. Growth hormone-releasing peptide (GHRP). Cell Mol Life Sci. 1998;54(12):1316-1329. PMID: 9893710. https://pubmed.ncbi.nlm.nih.gov/9893710/
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
